Production of Plasminogen Activators and Matrix Metalloproteinases by Endothelial Cells: Their Role in Fibrinolysis and Local Proteolysis

  • Victor W. M. van Hinsbergh
  • Pieter Koolwijk
Part of the NATO ASI Series book series (NSSA, volume 227)

Abstract

Matrices composed of fibrous proteins play an important role in the growth and repair of tissues. The complex extracellular matrix not only anchors the cell in the body, but it also provides the cell - via interaction with receptors and the cytoskeleton - with information about its position in the tissue. Various proteases, in particular plasmin, plasminogen activators (PAs) and matrix degrading metalloproteinases (MMPs) are involved in the regulation of the turnover and destruction of such matrices [Daneø et al., 1985; Saksela, 1985; Mignatti et al., 1986; Liotta et al., 1991].

Keywords

Polypeptide Histamine Gelatin Thrombin Triad 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A., and Stacey, S.N., 1990, Plasminogen activator inhibitors: hormonally regulated serpins, Molec. Cell. Endocrinol., 68:1.Google Scholar
  2. Bachmann, F., 1987, Fibrinolysis, in: “Thrombosis and Haemostasis 1987,” M. Verstraete, J. Vermylen, R. Lijnen, and J. Arnout, eds., Leuven University Press, Leuven, p. 227.Google Scholar
  3. Barnathan, E. S., Kuo, A., Rosenfeld, L., Karikó, K., Leski, M., Robbiati, F., Nolli, M. L., Henkin, J., and Cines, D. B., 1990a, Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells, J. Biol. Chem., 265:2865.Google Scholar
  4. Barnathan, E. S., Kuo, A., Karikó, K., Rosenfeld, L., Murray, S. C., Behrendt, N., Ronne, E., Weiner, D., Henkin, J., and Cines, D. B., 1990b, Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA, Blood, 76:1795.Google Scholar
  5. Bauer, K. A., Ten Cate H, Barzegar, S., Spriggs, D. R., Sherman, M. L., and Rosenberg, R. D., 1989, Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans, Blood, 74: 165PubMedGoogle Scholar
  6. Beebe, D. P., Miles, L. A., and Plow, E. F., 1989, A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor, Blood, 74:2034.PubMedGoogle Scholar
  7. Behrendt, N., Ronne, E., Ploug, M., Petri, T., Løber, D., Nielsen, L. S., Schleuning, W.-D., Blasi, F., Appella, E., and Danø, K., 1990, The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants, J. Biol. Chem., 265: 6453.PubMedGoogle Scholar
  8. Blasi, F., 1988, Surface receptors for urokinase plasminogen activator, Fibrinolysis, 2:73.Google Scholar
  9. Case, J. P., Lafyatis, R., Remmers, E. F., Kumkumian, G. K., and Wilder, R. L., 1989, Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes, Am. J. Pathol., 135:1055.PubMedGoogle Scholar
  10. Colucci, M., Paramo, J. A., and Collett, D., 1985, Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation, J. Clin. Invest., 75:818.PubMedCrossRefGoogle Scholar
  11. Cubellis, M. V., Wun, T.-C., and Blasi, F., 1990, Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1, EMBO J., 9:1079.PubMedGoogle Scholar
  12. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L., 1985, Plasminogen activators, tissue degradation and cancer, Adv. Cancer Res., 44:139.PubMedCrossRefGoogle Scholar
  13. DeClerck, Y. A., Yean, T.-D., Ratzkin, B. J., Lu, H. S., and Langley, K. E., 1989, Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells, J. Biol. Chem., 264:17445.Google Scholar
  14. Diamond, S. L., Eskin, S. G., and McIntire, L. V., 1989, Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells, Science, 243:1483.PubMedCrossRefGoogle Scholar
  15. Docherty, A. J. P., and Murphy, G., 1990, The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins, Ann. Rheumatic Diseases, 49:469.Google Scholar
  16. Emeis, J. J., 1988, Mechanisms involved in short-term changes in blood levels of t-PA, in: “Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects,” C. Kluft, ed., CRC Press Inc., Boca Raton, FL), Vol. II, p. 21.Google Scholar
  17. Estreicher, A., Mühlhauser, J., Carpentier, J.-L., Orci, L., and Vassalli, J.-D., 1990, The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes, J. Cell Biol., 111:783.PubMedCrossRefGoogle Scholar
  18. Fràter-Schröder, M., Risau, W., Hallmann, R., Gautschi, P., and Böhlen P, 1987, Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo, Proc. Nat. Acad. Sci. USA., 84:5277.PubMedCrossRefGoogle Scholar
  19. Friezner Degen, S. J., Rajput, B., and Reich, E., 1986, The human tissue plasminogen activator gene, J. Biol. Chem., 261:6972.Google Scholar
  20. Frisch, S. M., Clark, E. J., and Werb, Z., 1987, Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes, Proc. Natl. Acad. Sci. USA, 84:2600.PubMedCrossRefGoogle Scholar
  21. Ginsburg, D., Zeheb, R., Yang, A. Y., Rafferty, U. M., Andreasen, P. A., Nielsen, L., Danø, K., Lebo, R. V., and Gelehrter, T. D., 1986, cDNA cloning of human plasminogen activator-inhibitor from endothelial cells, J. Clin. Invest., 78:1673.PubMedCrossRefGoogle Scholar
  22. Goldfarb, R. H., Ziche, M., Murano, G., and Liotta, L. A., 1986, Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis, Semin. Thromb. Hemostas., 12:337.CrossRefGoogle Scholar
  23. Gross, J. L., Moscatelli, D., Jaffe, E. A., and Rifkin, D. B., 1982, Plasminogen activator and collagenase production by cultured capillary endothelial cells, J. Cell Biol., 95:974.PubMedCrossRefGoogle Scholar
  24. Gross, J. L., Moscatelli, D., and Rifkin, D. B., 1983, Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro, Proc. Nat. Acad. Sci. USA, 80:2623.PubMedCrossRefGoogle Scholar
  25. Grülich-Henn, J., and Müller-Berghaus, G., 1990, Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin, Blut, 61:38.PubMedCrossRefGoogle Scholar
  26. Hajjar, K. A., and Nachman, R. L., 1988, Endothelial cell-mediated conversion of glu-plasminogen to lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface, J. Clin. Invest., 82:1769.PubMedCrossRefGoogle Scholar
  27. Hajjar, K. A., Gavish, D., Breslow, J. L., and Nachman, R. L., 1989, Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis, Nature, 339:303.PubMedCrossRefGoogle Scholar
  28. Hajjar, K. A., and Hamel, N. M., 1990, Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase, J. Biol. Chem., 265:2908.PubMedGoogle Scholar
  29. Harpel, P. C., Silverstein, R. L., Pannell, R., Gurewich, V., and Nachman, R. L., 1990, Thrombospondin forms complexes with single-chain and two-chain forms of urokinase, J. Biol. Chem., 265:11289.PubMedGoogle Scholar
  30. Hart, D. A., and Fritzler, M. J., 1989, Regulation of plasminogen activators and their inhibitors in rheumatic diseases: new understanding and the potential for new directions, J. Rheumatol. 16:1184.PubMedGoogle Scholar
  31. Hébert, C. A., and Baker, J. B., 1988, Linkage of extracellular plasminogen activator to the fibroblast cystoskeleton: colocalization of cell surface urokinase with vinculin, J. Cell Biol., 106:1241.PubMedCrossRefGoogle Scholar
  32. Herron, G. S., Werb, Z., Dwyer, K., Banda, M. J., 1986a, Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity, J. Biol. Chem., 261:2810.Google Scholar
  33. Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., and Werb, Z., 1986b, Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors, J. Biol. Chem., 261:2814.Google Scholar
  34. Holmes, W. E., Nelles, L., Lijnen, H. R., and Collen, D., 1987, Primary structure of human a2-antiplasmin, a serine protease inhibitor (Serpin), J. Biol. Chem., 262:1659.PubMedGoogle Scholar
  35. Konkle, B. A., Kollros, P. R., and Kelly, M. D., Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways, J. Biol. Chem., 265:21867.Google Scholar
  36. Kooistra, T., Van den Berg, J., Töns, A., Platenburg, G., Rijken, D. C., and Van den Berg, E. A., 1987, Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells, Biochem. J. 247:605.PubMedGoogle Scholar
  37. Kooistra, T., Bosma, P. J., Toet, K., Cohen, L. H., Griffioen, M., Van den Berg, E., le Clercq, L., and Van Hinsbergh, V. W. M., 1991a, Role of protein kinase C and cAMP in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor 1 and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos, Arteriosclerosis and Thrombosis, 11:1042.CrossRefGoogle Scholar
  38. Kooistra, T., Opdenberg, J. P., Toet, K., Hendriks, H. F. J., Van den Hoogen, R. M., and Emeis, J. J., 1991b, Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo, Thromb. Haemostas., 65:565.Google Scholar
  39. Kruithof, E. K. O., Tran-Thang, C., Gudinchet, A., Hauert, J., Nicoloso, G., Genton, C., Welti, H., and Bachmann, F., 1987, Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors, Blood, 69: 460.PubMedGoogle Scholar
  40. Kruithof, E. K. O., Gudinchet, A., and Bachmann, F., 1988, Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states, Thromb. Haemostas. 59:7.Google Scholar
  41. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., and Nuseir, N., 1987, Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α, Nature, 329:630.PubMedCrossRefGoogle Scholar
  42. Levin, E. G., and Santell, L., 1988, Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells, J. Biol. Chem., 263:9360.PubMedGoogle Scholar
  43. Levin, E. G., Marotti, K. R., and Santell, L., 1989, Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA, J. Biol. Chem., 264:16030.PubMedGoogle Scholar
  44. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G., 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell, 64:327.PubMedCrossRefGoogle Scholar
  45. Medcalf, R. L., Rüegg, M., and Schleuning, W.-D., 1990, A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal exxpression and convey activation by phorbol ester and cAMP, J. Biol. Chem., 265:14618.PubMedGoogle Scholar
  46. Mignatti, P., Robbins, E., and Rifkin, D.B., 1986, Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade, Cell, 47:487.PubMedCrossRefGoogle Scholar
  47. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D.B., 1989, In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases, J. Cell Biol., 108: 671.PubMedCrossRefGoogle Scholar
  48. Mignatti, P., Mazzieri, R., and Rifkin, D. B., 1991, Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor, J. Cell Biol., 113:1193.PubMedCrossRefGoogle Scholar
  49. Miles, L. A., and Plow, E. F., 1988, Plasminogen receptors: ubiquitous sites for cellular regulation of fibrinolysis, Fibrinolysis, 2:61.Google Scholar
  50. Miles, L. A., Levin, E. G., Plescia, J., Collen, D., and Plow, E. F., 1988, Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells, Blood, 72:628.PubMedGoogle Scholar
  51. Miles, L. A., Dahlberg, C. M., Levin, E. G., and Plow, E. F., 1989a, Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells, Biochemistry, 28:9337.CrossRefGoogle Scholar
  52. Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., and Plow, E. F., 1989b, A potential basis for the thrombotic risks associated with lipoprotein(a) Nature, 339:301.Google Scholar
  53. Montesano, R., Pepper, M. S., Vassalli, J.-D., and Orci, L., 1987, Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors, J. Cell. Physiol., 132:509.PubMedCrossRefGoogle Scholar
  54. Moscatelli, D., Rifkin, D. B., and Jaffe, E. A., 1985, Production of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations, Exp. Cell Res., 156:379.CrossRefGoogle Scholar
  55. Moscatelli, D., 1987, High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells J. Cell. Physiol., 131:123.PubMedCrossRefGoogle Scholar
  56. Müllertz, S., 1987, Fibrinolysis. General aspects, characteristic features and perspectives, Fibrinolysis, 1:3.Google Scholar
  57. Ny, T., Sawdey, M., Lawrence, D., Millan, J. L., and Loskutoff, D. J., 1986, Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor, Proc. Natl. Acad. Sci. USA, 83:6776.PubMedCrossRefGoogle Scholar
  58. Pannekoek, H., Veerman, H., Lambers, H., Diergaarde, P., Verweij, C. L., Van Zonneveld, A.-J., and Van Mourik, J. A., 1986, Endothelial plasminogen activator inhibitor (PAI): a new member of the serpin gene family, EMBO J., 5:2539.PubMedGoogle Scholar
  59. Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., and Goeddel, D. V., 1983, Cloning and expression of human tissue-type plasminogen activator cDNA in E.coli, Nature, 301:214.PubMedCrossRefGoogle Scholar
  60. Pepper, M. S., Vassalli, J.-D., Montesano, R., and Orci, L., 1987, Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells, J. Cell Biol., 105:2535.PubMedCrossRefGoogle Scholar
  61. Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J.-D., 1990, Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro, J. Cell Biol. 111:743.PubMedCrossRefGoogle Scholar
  62. Petersen, T. E., Martzen, M. R., Ichinose, A., and Davie, E. W., 1990, Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system, J. Biol. Chem., 265:6104.PubMedGoogle Scholar
  63. Ploug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., and Danø, K., 1991, Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosylphosphatidylinositol, J. Biol. Chem., 266:1926.PubMedGoogle Scholar
  64. Pöllänen, J., Hedman, K., Nielsen, L. S., Dan0, K., and Vaheri, A., 1988, Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts, J. Cell Biol., 106:87.PubMedCrossRefGoogle Scholar
  65. Preissner, K. T., Grulich-Henn, J., Ehrlich, H. J., Declerck, P., Justus, C., Collen, D., Pannekoek, H., and Muller-Berghaus, G., Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin, J. Biol. Chem., 265:18490.Google Scholar
  66. Quax, P. H. A., Van den Hoogen, C. M., Verheijen, J. H., Padró, T., Zeheb, R., Gelehrter, T. D., Van Berkel, Th. J. C., Kuiper, J., and Emeis, J. J., 1990, Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo, J. Biol. Chem., 265:15560.PubMedGoogle Scholar
  67. Rånby, M., 1982, Studies on the kinetics of plasminogen activation by tissue plasminogen activator, Biochim. Biophys. Acta, 704:461.Google Scholar
  68. Riccio, A., Grimaldi, G., Verde, P., Sebastio, G., Boast, S., and Blasi, F., 1985, The human urokinase plasminogen activator gene and its promoter, Nucl. Acids Res., 13:2759.CrossRefGoogle Scholar
  69. Rijken, D. C., Hoylaerts, M., and Collen, D., 1982, Fibrinolytic properties of one-chain and twO-chain human extrinsic (tissue-type) plasminogen activator, J. Biol. Chem., 257:2920.PubMedGoogle Scholar
  70. Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Daneø, K., Appella, E., and Blasi, F., 1990, Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis, EMBO J., 9: 467.PubMedGoogle Scholar
  71. Saksela, O., 1985, Plasminogen activation and regulation of pericellular proteolysis, Biochim. Biophys. Acta, 823:35.PubMedGoogle Scholar
  72. Saksela, O., Moscatelli, D., and Rifkin, D. B., 1987, The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells, J. Cell Biol. 105:957.PubMedCrossRefGoogle Scholar
  73. Saksela, O., and Rifkin, D. B., 1990, Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity J. Cell Biol., 110:767.PubMedCrossRefGoogle Scholar
  74. Salonen, E.-M., Zitting, A., and Vaheri, A., 1984, Laminin interacts with plasminogen and its tissue-type activator, FEBS Lett. 172:29.PubMedCrossRefGoogle Scholar
  75. Salonen, E.-M., Saksela, O., Vartio, T., Vaheri, A., Nielsen, L. S., and Zeuthen, J., 1985, Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin, J. Biol. Chem., 260:12302.PubMedGoogle Scholar
  76. Santell, L., and Levin, E. G., 1988, Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells, J. Biol. Chem., 263:16802.PubMedGoogle Scholar
  77. Sato, Y., and Rifkin, D. B., 1988, Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis, J. Cell Biol., 107:1199.PubMedCrossRefGoogle Scholar
  78. Sato, Y., Tsuboi, R., Lyons, R., Moses, H., and Rifkin, D. B., 1990, Characterization of the activation of latent TGF-Q by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system, J. Cell Biol., 111:757.PubMedCrossRefGoogle Scholar
  79. Schleef, R. R., Bevilacqua, M. P., Sawdey, M., Gimbrone, M. A., Jr., and Loskutoff, D. J., 1988, Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor, J. Biol. Chem., 263:5797.PubMedGoogle Scholar
  80. Schleef, R. R., and Loskutoff, D. J., 1988, Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors, Haemostasis, 18:328.PubMedGoogle Scholar
  81. Silverstein, R. L., Leung, L. L. K., and Nachman, R. L., 1986, Thrombospondin: a versatile multifunctional glycoprotein, Arteriosclerosis, 6:245.PubMedCrossRefGoogle Scholar
  82. Sprengers, E. D., and Kluft, C., 1987, Plasminogen activator inhibitors, Blood, 69:381.PubMedGoogle Scholar
  83. Suffredini, A. F., Harpel, P. C., and Parrillo, J. E., 1989, Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects, New Engl. J. Med. 320: 1165.CrossRefGoogle Scholar
  84. Tsuboi, R., Sato, Y., and Rifkin, D. B., 1990, Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells, J. Cell Biol. 110:511.CrossRefGoogle Scholar
  85. Unemori, E. N., Bouhana, K. S., and Werb, Z., 1990, Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells, J. Biol. Chem., 265:445.PubMedGoogle Scholar
  86. Van Deventer, S. J. H., Büller, H. R., Ten Cate, J. W., Aarden, L. A., Hack, E., and Sturk, A., 1990, Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways, Blood, 76:2520.PubMedGoogle Scholar
  87. Van Hinsbergh, V. W. M., 1988a, Regulation of the synthesis and secretion of plasminogen activators by endothelial cells, Haemostasis, 18:307.Google Scholar
  88. Van Hinsbergh, V. W. M., 1988b, Synthesis and secretion of plasminogen activators and plasminogen activator inhibitor by endothelial cells, in: “Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects,” C. Kluft, ed., CRC Press Inc., Boca Raton, FL, Vol. II, p. 3.Google Scholar
  89. Van Hinsbergh, V. W. M., Kooistra, T., Van den Berg, E. A., Princen, H. M. G., Fiers, W., and Emeis, J. J., 1988, Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo, Blood, 72:1467.PubMedGoogle Scholar
  90. Van Hinsbergh, V. W. M., 1990, Coagulation and fibrinolysis in vascular occlusion and repair, in: “Applied Cardiovascular Biology 1989,” P. Zilla, R. Fasol, and A. Callow, eds., Int. Soc. Appl. Cardiovasc. Biol. Karger, Basel, Vol. 1, p. 73.Google Scholar
  91. Van Hinsbergh, V. W. M., Van den Berg, E. A., Fiers, W., and Dooijewaard, G., 1990a, Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells, Blood, 75: 1991.Google Scholar
  92. Van Hinsbergh, V. W. M., Bauer, K. A., Kooistra, T., Kluft, C., Dooijewaard, G., Sherman, M. L., and Nieuwenhuizen, W., 1990b, Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products, Blood, 76:2284.Google Scholar
  93. Van Zonneveld, A. J., Veerman, H., and Pannekoek, H., 1986, On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin J. Biol. Chem., 261:14214.PubMedGoogle Scholar
  94. Verheijen, J. H., Gaspers, M. P. M., Chang, G. T. G., De Munk, G. A. W., Pouwels, P. H., and Enger-Valk, B. E., 1986, Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin, Eur. Mol. Biol. Organisat. J., 5:3525.Google Scholar
  95. Wallén, P., 1987, Structure and function of tissue plasminogen activator and urokinase, in: “Fundamental and Clinical Fibrinolysis,” Castellino, P. J. Gaffney, M. M. Samama, and Takada, eds., Elsevier, Amsterdam, p. 1.Google Scholar
  96. Wohlwend, A., Belin, D., and Vassalli, J.-D., 1987, Plasminogen activator-specific inhibitors produced by human monocytes/macrophages, J. Exp. Med., 165:320.PubMedCrossRefGoogle Scholar
  97. Wun, T.-C., and Capuano, A., 1985, Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro, J. Biol. Chem., 260:5061.PubMedGoogle Scholar
  98. Ye, R. D., Wun, T.-C., and Sadler, J. E., 1987, cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta, J. Biol. Chem., 262:3718.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Victor W. M. van Hinsbergh
    • 1
  • Pieter Koolwijk
    • 1
  1. 1.Gaubius LaboratoryIVVO-TNOLeidenThe Netherlands

Personalised recommendations